Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1986 Oct;89(2):415–422. doi: 10.1111/j.1476-5381.1986.tb10275.x

Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.

J L Wallace, B J Whittle
PMCID: PMC1917013  PMID: 3096408

Abstract

The effects of several inhibitors of arachidonic acid metabolism on gastric necrosis, hypotension, haemoconcentration, leukopenia and plasma exudation induced by platelet-activating factor (Paf) were studied in the rat. A 10 min intravenous infusion of Paf (100 ng kg-1 min-1) caused extensive gastric damage and a marked fall in systemic blood pressure which had not recovered to basal levels 30 min after the infusion had been terminated. Paf also caused significant haemoconcentration, plasma exudation and transient leukopenia. Pretreatment with dexamethasone (0.2 or 2 mg kg-1 s.c.) or prednisolone (20 mg kg-1 s.c.) two hours before Paf significantly reduced the gastric damage and accelerated the recovery of blood pressure after the Paf infusion. Likewise, BW755C (50 mg kg-1 p.o.) significantly reduced the gastric damage. Acute pretreatment with dexamethasone (2 mg kg-1 i.v.) 15 min before Paf, or with indomethacin (5 mg kg-1 s.c.), acetylsalicylic acid (10 mg kg-1 i.v.) or 1-benzylimidazole (50 mg kg-1 s.c.) did not significantly affect the gastric damage induced by Paf. The Paf-induced haemoconcentration and plasma exudation were significantly reduced by pretreatment with prednisolone (20 mg kg-1 s.c.) or BW755C (50 mg kg-1 p.o.), while Paf-induced leukopenia was unaffected by either drug. These studies indicate that cyclo-oxygenase products of arachidonic acid are unlikely to contribute significantly to the gastric damage or the prolonged hypotension induced by Paf. The ability of corticosteroids and BW755C to reduce the gastric damage, haemoconcentration and plasma exudation suggests that lipoxygenase products of arachidonic acid may contribute to these actions of Paf.

Full text

PDF
415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer C. B., Frohlich W., Page C. W., Paul W., Morley J., MacDonald D. M. Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man. Prostaglandins. 1984 Mar;27(3):495–501. doi: 10.1016/0090-6980(84)90207-7. [DOI] [PubMed] [Google Scholar]
  2. Benveniste J. Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils. Nature. 1974 Jun 7;249(457):581–582. doi: 10.1038/249581a0. [DOI] [PubMed] [Google Scholar]
  3. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  4. Bourgain R. H., Maes L., Braquet P., Andries R., Touqui L., Braquet M. The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. Prostaglandins. 1985 Aug;30(2):185–197. doi: 10.1016/0090-6980(85)90184-4. [DOI] [PubMed] [Google Scholar]
  5. Camussi G., Tetta C., Bussolino F. Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit. Prostaglandins. 1983 Mar;25(3):343–351. doi: 10.1016/0090-6980(83)90037-0. [DOI] [PubMed] [Google Scholar]
  6. Chilton F. H., O'Flaherty J. T., Walsh C. E., Thomas M. J., Wykle R. L., DeChatelet L. R., Waite B. M. Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. J Biol Chem. 1982 May 25;257(10):5402–5407. [PubMed] [Google Scholar]
  7. Dahlén S. E., Björk J., Hedqvist P., Arfors K. E., Hammarström S., Lindgren J. A., Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3887–3891. doi: 10.1073/pnas.78.6.3887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Doebber T. W., Wu M. S., Shen T. Y. Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. Biochem Biophys Res Commun. 1984 Dec 28;125(3):980–987. doi: 10.1016/0006-291x(84)91380-9. [DOI] [PubMed] [Google Scholar]
  9. Flower R. J., Blackwell G. J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 1979 Mar 29;278(5703):456–459. doi: 10.1038/278456a0. [DOI] [PubMed] [Google Scholar]
  10. Hsueh W., Gonzalez-Crussi F., Arroyave J. L. Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Am J Pathol. 1986 Feb;122(2):231–239. [PMC free article] [PubMed] [Google Scholar]
  11. Iñarrea P., Gomez-Cambronero J., Nieto M., Crespo M. S. Characteristics of the binding of platelet-activating factor to platelets of different animal species. Eur J Pharmacol. 1984 Oct 15;105(3-4):309–315. doi: 10.1016/0014-2999(84)90623-x. [DOI] [PubMed] [Google Scholar]
  12. McGivern D. V., Basran G. S. Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man. Eur J Pharmacol. 1984 Jun 15;102(1):183–185. doi: 10.1016/0014-2999(84)90356-x. [DOI] [PubMed] [Google Scholar]
  13. McManus L. M., Hanahan D. J., Demopoulos C. A., Pinckard R. N. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J Immunol. 1980 Jun;124(6):2919–2924. [PubMed] [Google Scholar]
  14. Mencia-Huerta J. M., Benveniste J. Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur J Immunol. 1979 May;9(5):409–415. doi: 10.1002/eji.1830090512. [DOI] [PubMed] [Google Scholar]
  15. Myers A., Ramey E., Ramwell P. Glucocorticoid protection against PAF-acether toxicity in mice. Br J Pharmacol. 1983 Jun;79(2):595–598. doi: 10.1111/j.1476-5381.1983.tb11034.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nicholson D. P. Glucocorticoids in the treatment of shock and the adult respiratory distress syndrome. Clin Chest Med. 1982 Jan;3(1):121–132. [PubMed] [Google Scholar]
  17. Parente L., Fitzgerald M. F., Flower R. J., De Nucci G. The effect of glucocorticoids on lyso-PAF formation in vitro and in vivo. Agents Actions. 1986 Jan;17(3-4):312–313. doi: 10.1007/BF01982631. [DOI] [PubMed] [Google Scholar]
  18. Parente L., Flower R. J. Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. Life Sci. 1985 Apr 1;36(13):1225–1231. doi: 10.1016/0024-3205(85)90266-8. [DOI] [PubMed] [Google Scholar]
  19. Peskar B. M., Lange K., Hoppe U., Peskar B. A. Ethanol stimulates formation of leukotriene C4 in rat gastric mucosa. Prostaglandins. 1986 Feb;31(2):283–293. doi: 10.1016/0090-6980(86)90054-7. [DOI] [PubMed] [Google Scholar]
  20. Robert A., Nezamis J. E., Lancaster C., Hanchar A. J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 1979 Sep;77(3):433–443. [PubMed] [Google Scholar]
  21. Rosam A. C., Wallace J. L., Whittle B. J. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature. 1986 Jan 2;319(6048):54–56. doi: 10.1038/319054a0. [DOI] [PubMed] [Google Scholar]
  22. Salmon J. A., Simmons P. M., Moncada S. The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation. J Pharm Pharmacol. 1983 Dec;35(12):808–813. doi: 10.1111/j.2042-7158.1983.tb02901.x. [DOI] [PubMed] [Google Scholar]
  23. Smith R. J., Bowman B. J. Stimulation of human neutrophil degranulation with 1-O-octadecyl-2-O-acetyl-SN-glyceryl-3-phosphorylcholine: modulation by inhibitors of arachidonic acid metabolism. Biochem Biophys Res Commun. 1982 Feb 26;104(4):1495–1501. doi: 10.1016/0006-291x(82)91420-6. [DOI] [PubMed] [Google Scholar]
  24. Vargaftig B. B., Chignard M., Benveniste J., Lefort J., Wal F. Background and present status of research on platelet-activating factor (PAF-acether). Ann N Y Acad Sci. 1981;370:119–137. doi: 10.1111/j.1749-6632.1981.tb29727.x. [DOI] [PubMed] [Google Scholar]
  25. Wallace J. L., Whittle B. J. Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins. 1986 May;31(5):989–998. doi: 10.1016/0090-6980(86)90028-6. [DOI] [PubMed] [Google Scholar]
  26. Wallace J. L., Whittle B. J. Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor. Eur J Pharmacol. 1986 May 13;124(1-2):209–210. doi: 10.1016/0014-2999(86)90148-2. [DOI] [PubMed] [Google Scholar]
  27. Wallace J. L., Whittle B. J. Role of prostanoids in the protective actions of BW755C on the gastric mucosa. Eur J Pharmacol. 1985 Sep 10;115(1):45–52. doi: 10.1016/0014-2999(85)90582-5. [DOI] [PubMed] [Google Scholar]
  28. Whittle B. J., Kauffman G. L., Moncada S. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa. Nature. 1981 Jul 30;292(5822):472–474. doi: 10.1038/292472a0. [DOI] [PubMed] [Google Scholar]
  29. Whittle B. J., Oren-Wolman N., Guth P. H. Gastric vasoconstrictor actions of leukotriene C4, PGF2 alpha, and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo. Am J Physiol. 1985 May;248(5 Pt 1):G580–G586. doi: 10.1152/ajpgi.1985.248.5.G580. [DOI] [PubMed] [Google Scholar]
  30. Young J. M., Maloney P. J., Jubb S. N., Clark J. S. Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse. Prostaglandins. 1985 Oct;30(4):545–551. doi: 10.1016/0090-6980(85)90018-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES